Healthcare provider profile · identity verified

David Zeda, MD

Internal Medicine · JUPITER, FL · NPI 1427042787

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	782	246
Rosuvastatin Calcium	Rosuvastatin Calcium	590	185
Levothyroxine Sodium	Levothyroxine Sodium	586	168
Losartan Potassium	Losartan Potassium	529	159
Amlodipine Besylate	Amlodipine Besylate	513	161
Simvastatin	Simvastatin	393	111
Metoprolol Succinate	Metoprolol Succinate	374	112
Lisinopril	Lisinopril	358	114
Omeprazole	Omeprazole	355	116
Metformin Hcl	Metformin Hcl	301	91
Hydrochlorothiazide	Hydrochlorothiazide	252	75
Furosemide	Furosemide	219	78
Tamsulosin Hcl	Tamsulosin Hcl	206	68
Eliquis	Apixaban	199	55
Pantoprazole Sodium	Pantoprazole Sodium	183	58
Gabapentin	Gabapentin	181	57
Alprazolam	Alprazolam	170	59
Escitalopram Oxalate	Escitalopram Oxalate	169	49
Clopidogrel	Clopidogrel Bisulfate	150	46
Potassium Chloride	Potassium Chloride	143	47
Meloxicam	Meloxicam	136	44
Temazepam	Temazepam	131	22
Metoprolol Tartrate	Metoprolol Tartrate	130	39
Albuterol Sulfate Hfa	Albuterol Sulfate	125	47
Alendronate Sodium	Alendronate Sodium	115	37
Zolpidem Tartrate	Zolpidem Tartrate	112	19
Allopurinol	Allopurinol	102	35
Famotidine	Famotidine	101	32
Carvedilol	Carvedilol	93	28
Donepezil Hcl	Donepezil Hcl	92	25
Duloxetine Hcl	Duloxetine Hcl	88	34
Sertraline Hcl	Sertraline Hcl	87	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	26
Ezetimibe	Ezetimibe	79	29
Pravastatin Sodium	Pravastatin Sodium	79	21
Chlorthalidone	Chlorthalidone	77	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	76	59
Atenolol	Atenolol	76	26
Valsartan	Valsartan	76	23
Mirtazapine	Mirtazapine	74	23
Trazodone Hcl	Trazodone Hcl	72	22
Ipratropium Bromide	Ipratropium Bromide	69	32
Jardiance	Empagliflozin	68	13
Fluticasone Propionate	Fluticasone Propionate	66	30
Nifedipine Er	Nifedipine	66	21
Glipizide	Glipizide	64	21
Sildenafil Citrate	Sildenafil Citrate	64	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	62	45
Methylprednisolone	Methylprednisolone	61	52
Montelukast Sodium	Montelukast Sodium	60	23
Azithromycin	Azithromycin	58	54
Ozempic	Semaglutide	58	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	31
Prednisone	Prednisone	57	33
Hydralazine Hcl	Hydralazine Hcl	56	18
Ibuprofen	Ibuprofen	56	24
Doxycycline Hyclate	Doxycycline Hyclate	54	48
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	12
Fenofibrate	Fenofibrate	50	15
Lorazepam	Lorazepam	49	13
Lovastatin	Lovastatin	49	15
Spironolactone	Spironolactone	48	21
Celecoxib	Celecoxib	47	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	41
Diclofenac Sodium	Diclofenac Sodium	45	15
Finasteride	Finasteride	45	15
Diazepam	Diazepam	44	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Ketoconazole	Ketoconazole	39	33
Citalopram Hbr	Citalopram Hydrobromide	38	11
Glipizide Er	Glipizide	37	12
Metformin Hcl Er	Metformin Hcl	37	13
Irbesartan	Irbesartan	35	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Vascepa	Icosapent Ethyl	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	11
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	12
Paxlovid	Nirmatrelvir/Ritonavir	33	33
Naproxen	Naproxen	32	suppressed
Clonidine Hcl	Clonidine Hcl	30	12
Tramadol Hcl	Tramadol Hcl	30	15
Buspirone Hcl	Buspirone Hcl	29	suppressed
Telmisartan	Telmisartan	28	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Prolia	Denosumab	24	18
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Xarelto	Rivaroxaban	24	11
Januvia	Sitagliptin Phosphate	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Cefdinir	Cefdinir	22	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	12
Novolog	Insulin Aspart	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Cephalexin	Cephalexin	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Tradjenta	Linagliptin	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Anastrozole	Anastrozole	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Acetic Acid	Acetic Acid	15	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Baclofen	Baclofen	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amoxicillin	Amoxicillin	13	13
Carisoprodol	Carisoprodol	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Lactulose	Lactulose	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Zemaira	Alpha-1-Proteinase Inhibitor	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Linzess	Linaclotide	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Metolazone	Metolazone	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nystatin	Nystatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Ramipril	Ramipril	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error